Derivatives and Risk Management Activities |
11. Derivative and Risk Management Activities
The Company’s principal market exposure is to interest rate risk, specifically long-term U.S. Treasury and mortgage interest rates, due to their impact on mortgage-related assets and commitments. The Company is also subject to changes in short-term interest rates, such as LIBOR and SOFR, due to their impact on certain variable rate asset-backed debt such as warehouse lines of credit. Various financial instruments are used to manage and reduce this risk, including forward delivery commitments on MBS or whole loans and interest rate swaps.
The Company did not have any derivative instruments designated as hedging instruments as of September 30, 2022 or December 31, 2021.
The following tables summarize the fair value and notional amount of derivative instruments (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2022 |
|
Derivative assets |
|
Derivative liabilities |
|
Fair value |
|
Notional amount |
|
|
Fair value |
|
Notional amount |
|
|
IRLCs and LPCs |
$ |
3,678
|
|
|
$ |
344,617
|
|
|
|
$ |
13,740
|
|
|
$ |
590,007
|
|
|
|
Forward MBS and TBAs |
32,254
|
|
|
1,162,300
|
|
|
|
97
|
|
|
15,071
|
|
|
|
Interest rate swaps and futures contracts |
53,967
|
|
|
1,430,600
|
|
|
|
— |
|
|
—
|
|
|
|
Total fair value and notional amount |
$ |
89,899
|
|
|
$ |
2,937,517
|
|
|
|
$ |
13,837
|
|
|
$ |
605,078
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
Derivative assets |
|
Derivative liabilities |
|
Fair value |
|
Notional amount |
|
|
Fair value |
|
Notional amount |
|
|
IRLCs and LPCs |
$ |
24,786 |
|
|
$ |
2,095,238 |
|
|
|
$ |
— |
|
|
$ |
— |
|
|
|
Forward MBS and TBAs |
1,250 |
|
|
948,000 |
|
|
|
1,685 |
|
|
1,515,000 |
|
|
|
Interest rate swaps and futures contracts |
22,834 |
|
|
11,977,300 |
|
|
|
24,993 |
|
|
12,193,100 |
|
|
|
Total fair value and notional amount |
$ |
48,870 |
|
|
$ |
15,020,538 |
|
|
|
$ |
26,678 |
|
|
$ |
13,708,100 |
|
|
|
The follow table details the gains/(losses) on derivative instruments (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the three months ended September 30, 2022 |
|
For the nine months ended September 30, 2022 |
|
For the three months ended September 30, 2021 |
|
For the six months ended September 30, 2021 |
|
|
For the three months ended March 31, 2021 |
Derivative activity |
|
Successor |
|
|
Predecessor |
IRLCs and LPCs |
|
$ |
(24,189) |
|
|
$ |
(34,848) |
|
|
$ |
(5,119) |
|
|
$ |
(8,656) |
|
|
|
$ |
(49,557) |
|
Forward MBS and TBAs |
|
54,856
|
|
|
265,822
|
|
|
(8,349) |
|
|
(48,638) |
|
|
|
113,331 |
|
Interest rate swaps and futures contracts |
|
53,123
|
|
|
292,666
|
|
|
1,254 |
|
|
(36,129) |
|
|
|
43,935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company is exposed to risk in the event of nonperformance by counterparties in their derivative contracts. In general, the Company manages such risk by evaluating the financial position and creditworthiness of counterparties, monitoring the amount of exposure and/or dispersing the risk among multiple counterparties. The Company either maintains or deposits cash as margin collateral with its counterparties to the extent the relative value of its derivatives are above or below their initial strike price. The Company held collateral from its counterparties of $75.6 million as of September 30, 2022 and had provided collateral to its counterparties of $23.2 million as of December 31, 2021. The Company does not offset fair value amounts recognized for derivative instruments with amounts collected or deposited on derivative instruments in the Company’s Condensed Consolidated Statements of Financial Condition. Margin collateral is included in other assets, net, when in a receivable position or in payables and other liabilities when in a payable position in the Company's Condensed Consolidated Statements of Financial Condition.
|